Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, February, 2009 - PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period December 2008 to January 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period December 2008 to January 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca RECENTIN Recurrent glioblastoma multiforme and colorectal cancer IMC Medical Communication
AstraZeneca ZD4054 Prostate cancer IMC Medical Communication
Baxter Europe Advate and FEIBA Haemophilia Ashley Communications
Roche Pegasys Hepatitis C and B Ketchum
Sanofi-aventis/ Bristol-Myers Squibb n/a Cardiovascular Medaxial
SPD Development Company Clearblue digital pregnancy test with conception indicator Women's health IMC Medical Communication
Typharm Dermatology portfolio Dermatology echo
TOPRA Corporate n/a Ash Healthcare
 Wyeth  ReFacto Haemophilia ROAD 

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

5th March 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics